Treatment of Legionella Pneumonia

First-Line Treatment Options

The American College of Physicians recommends fluoroquinolones, particularly levofloxacin, as the preferred first-line treatment for Legionella pneumonia due to their superior clinical outcomes, including more rapid defervescence, fewer complications, and shorter hospital stays compared to macrolides 1, 2
The Infectious Diseases Society of America recommends levofloxacin 750 mg IV/PO once daily for 7-10 days as a first-line treatment option for Legionella pneumonia 2, 3
Moxifloxacin 400 mg IV/PO once daily for 7-10 days is also a recommended first-line treatment option for Legionella pneumonia 2

The standard treatment duration for immunocompetent patients with Legionella pneumonia is 7-10 days 1, 4
Extended treatment (21 days) may be considered for immunosuppressed patients, severely ill patients at presentation, and patients with significant comorbidities 1, 4

The Centers for Disease Control and Prevention recommend intravenous therapy initially for hospitalized patients with Legionella pneumonia, with a switch to oral therapy once clinical improvement occurs and temperature has been normal for 24 hours 5, 6
Fluoroquinolones, particularly levofloxacin, have shown better outcomes in observational studies, with more rapid fever resolution, fewer complications, and shorter hospital stays 1, 4
Combination therapy may be considered for patients with severe disease, significant comorbidities, immunocompromised hosts, and patients refractory to conventional monotherapy 1, 4

The American Thoracic Society recommends that treatment for Legionella pneumonia be initiated as rapidly as possible after diagnosis, even with negative diagnostic test results if there is epidemiologic evidence of Legionella infection 5